Given the critical role of the YAP/TAZ pathway in modulating the tumor microenvironment and promoting drug resistance in cancer, targeting this pathway has emerged as a potential therapeutic strategy for cancer immunotherapy. The gene discussed is YAP1; the disease is cancer.